Former Stanford University president's AI start-up raises $1 billion
Image Credit: newsbytes
Xaira Therapeutics, a new entrant in the drug development industry, has successfully raised $1 billion in funding. The start-up is led by Marc Tessier-Lavigne, former President of Stanford University and now CEO of Xaira. The significant funding round includes contributions from influential Silicon Valley entities, such as Sequoia Capital and Lightspeed Venture Partners. Xaira's main goal is to utilize artificial intelligence to discover innovative drugs for disease treatment.